Anthropic, the company behind the Claude AI assistant, says it will set aside 5% of its shares for a new public benefit fund as it prepares for an initial public offering. The fund is designed to finance what the company calls “public good” work, including nonprofit grants and programs focused on how artificial intelligence affects jobs.
The unusual part is how the fund could grow. According to Reuters, on top of the initial 5%, the fund could receive an additional 2% of shares—at the board’s discretion—each time Anthropic’s valuation rises 50% above an undisclosed baseline. That means the fund’s resources could scale with the company’s market value, but it also hard-wires more share issuance into the company’s structure if things go well.
Anthropic is also drawing bright lines around politics. The company says shares held by the fund won’t be used for lobbying or political donations in the US or abroad, even as governments weigh tighter AI rules. This fits with Anthropic’s safety-first posture and its argument that AI could meaningfully reshape the labor market—a concern echoed by the IMF’s estimate that a large share of jobs could be changed or displaced.
What is a public benefit fund?
Public benefit funds are not new, but they are rare in the tech IPO world. They are typically set up by companies that want to dedicate a portion of their equity to social or environmental causes. The fund is usually controlled by the company itself, and its board decides how to distribute the money. In Anthropic’s case, the fund will be a company-controlled entity, meaning the company’s leadership will decide which nonprofits or programs get funding.
This structure is distinct from a traditional charitable foundation, which is independent and has its own board. By keeping control, Anthropic can align the fund’s spending with its own priorities, such as AI safety research or job-transition programs. But it also means the fund’s decisions are not entirely separate from the company’s commercial interests.
What does this mean for investors?
Most IPOs sell investors a fixed slice of future earnings. Anthropic’s plan adds an “if we win, we issue more shares” clause. Every big step-up in valuation can expand the stock set aside for the public benefit fund. In plain English, that can dilute existing shareholders, meaning a smaller piece of the company per share after those triggers hit.
Because the baseline is undisclosed and the extra 2% is discretionary, investors will likely treat the ratchet like an option-like claim on upside. They will factor it into IPO pricing and how they think about per-share gains after listing. For everyday investors, this means the headline valuation may not tell the whole story. If Anthropic’s value climbs sharply, the fund could end up holding a meaningful chunk of the company, reducing the value of each share you might own.
This is not the only wrinkle in Anthropic’s IPO math. The company is reportedly weighing a valuation of up to $1.5 trillion, and investors are already rethinking how to price the offering. The public benefit fund adds another layer of complexity.
Safety and governance questions
Anthropic has long positioned itself as a safety-first AI company. It has opened its Claude safety reviews to outside groups like METR, and it has faced pressure from public officials. New York City’s comptroller, for example, has urged Anthropic to delay its IPO over AI safety concerns. The public benefit fund could be seen as a way to address those concerns by committing a slice of the company’s value to public good work.
But the fund’s structure raises governance questions. Because the fund is company-controlled, its spending decisions are ultimately in the hands of the same executives who run the business. That could create conflicts of interest, especially if the fund’s grants are seen as benefiting the company’s reputation or lobbying efforts—even if direct political donations are barred.
Anthropic’s move also comes as governments around the world are considering tighter AI rules. The company’s stance on not using fund shares for lobbying may be an attempt to preempt criticism that it is trying to influence policy. Still, the fund’s existence could be seen as a way to burnish its image ahead of a high-profile IPO.
What to watch next
Investors will be watching several things as Anthropic moves toward its IPO. First, the exact baseline for the valuation ratchet—if it is ever disclosed—will be key. Second, how the board exercises its discretion on the extra 2% will matter. Third, the overall IPO pricing will reflect how much dilution investors expect from the fund.
For now, the public benefit fund is a notable experiment in corporate structure. It ties a company’s social commitments to its market success, but it also introduces a new form of dilution that investors will have to price in. As Anthropic’s IPO approaches, expect more debate over whether this is a genuine commitment to the public good or a clever way to manage optics.
For context on how other companies are handling similar challenges, consider Publicis’s recent earnings beat and its ability to maintain growth targets, or how China’s stock market is splitting as loan growth meets automaker risks. These stories show how companies and markets are navigating uncertainty in different sectors.
